The EGFR-Inhibitor Erlotinib Induces Differentiation, Cell Cycle Arrest and Apoptosis in EGFR-Negative Cells of MDS and AML.

Simone Boehrer; Lionel Adès; Thorsten Braun; Lorenzo Galluzzi; J. Grosjean; Claire Fabre; Geneviève Roux; Claude Gardin; Antoine Martin; Stéphane de Botton; Pierre Fenaux; Guido Guido Kroemer

doi:10.1182/blood.v110.11.399.399

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2011

Potentiation of Apoptosis in MDS/AML by Combination of Azacitidine and the EGFR-Tyrosine Kinase Inhibitor (TKI) erlotinib

Élodie Lainey, Marie Sébert, Cyrielle Bouteloup, Carole Leroy, Sylvain Thépot, Maximilien Tailler, Lionel Adès, Claude Gardin, Guido Guido Kroemer, Pierre Fenaux, Simone Boehrer

Article2007

P039 The EGFR-inhibitor erlotinib exhibits various off-target effects in MDS and AML

Simone Boehrer, L. Adàs, Theodore P. Braun, Lorenzo Galluzzi, Joël Grosjean, Claire Fabre, Stéphane de Botton, Claude Gardin, Pierre Fenaux, Guido Guido Kroemer

Article2007

Disruption of Bcl-2 Heterodimerization by the BH3 Mimetic ABT-737 Restores Spontaneous Apoptosis and Induces Differentiation in High Risk MDS and AML.

Lionel Adès, Simone Boehrer, Thorsten Braun, J. Grosjean, Claire Fabre, Pierre Fenaux, Guido Guido Kroemer

Article2007

Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study

Simone Boehrer, Lionel Adès, Thorsten Braun, Lorenzo Galluzzi, J. Grosjean, Claire Fabre, Geneviève Roux, Claude Gardin, Antoine Martin, Stéphane de Botton, Pierre Fenaux, Guido Guido Kroemer

Article2013

EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D<sub>3</sub>in acute myeloid leukemia cells

Élodie Lainey, Alice Wolfromm, Abdul Qader Sukkurwala, Jean‐Baptiste Micol, Pierre Fenaux, Lorenzo Galluzzi, Oliver Kepp, Guido Guido Kroemer